Chronic kidney disease
Conditions
Interventions
Exposed Group:None
Control Group:None
Sponsors
Army Military Medical University Second Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients who visited the study site for the first time and were clearly diagnosed with chronic renal failure combined with renal anemia; 2. Age greater than 18 years old; 3. Willing to participate in this study and sign the informed consent form
Exclusion criteria
Exclusion criteria: Individuals who have received treatment with Yisui Shengxue Granules,Hydroxyurea, Thalidomide,Decitabine, Azacitidine, Sirolimus, Butyrate salts, or Progestogens within the past 3 months prior to enrollment; Individuals with anemia caused by other reasons that has not been corrected; Individuals with Thrombocytopenia (PLT 450×10^9/L); Patients with severe cardiovascular or cerebrovascular diseases; Individuals who have recently experienced stress, such as extreme environmental temperatures (too low or too high), surgery, poisoning, fright, or high-altitude reactions; Pregnant or breastfeeding women, and women of childbearing age who are unwilling to use contraception; Patients currently participating in other clinical trials; Patients with organic heart disease, coronary artery insufficiency, significant Arrhythmias, pulse > 100/min, or severe hypertension; Patients with respiratory diseases such as Bronchiectasis, asthma, interstitial lung disease, chronic obstructive pulmonary disease (COPD), other types of respiratory insufficiency, or active pulmonary tuberculosis; Individuals with a history of professional athletic training.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the end of 12 months, %HbF increased from baseline levels; | — |
Secondary
| Measure | Time frame |
|---|---|
| MCHbF(12w)-MCHbF(0d); | — |
Countries
China
Contacts
Public ContactChen Li
Army Military Medical University Second Affiliated Hospital
Outcome results
None listed